Benzinga

Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Benzinga

Premium Services
Financial News
Latest
Earnings
Guidance
Dividends
M&A
Buybacks
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Small-Cap
Markets
Pre-Market
After Hours
Movers
ETFs
Options
Cryptocurrency
Commodities
Bonds
Futures
Mining
Real Estate
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Investing Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
Analyst Ratings
Analyst Color
Latest Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Unusual Options Activity Calendar

Stock Split Calendar

Trade Ideas

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Compare Best Stocks

Best Momentum Stocks

Best Quality Stocks

Best Value Stocks

Best Growth Stocks

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investor Events
Pre-market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2026 Benzinga | All Rights Reserved

September 22, 2022 6:34 AM 3 min read

Why Spero Therapeutics Is Trading Higher By Over 105%; Here Are 21 Stocks Moving Premarket

by Lisa Levin Benzinga Editor

Follow

Gainers

Don’t forget to check out our premarket coverage here .

Losers

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.

Posted In:

News Penny Stocks Small Cap Pre-Market Outlook Markets Movers Trading Ideas Communications Equipment Information Technology Top Gainers

BEATHeartBeam Inc

BNRGBrenmiller Energy Ltd

CMRAComera Life Sciences Holdings Inc

$0.00010-100.0%

CPHIChina Pharma Holding Inc

DBDeutsche Bank AG

ENSCEnsysce Biosciences Inc

FOXOFOXO Technologies Inc

NVAXNovavax Inc

OCULOcular Therapeutix Inc

SLNHSoluna Holdings Inc

SMRTSmartRent Inc

SPROSpero Therapeutics Inc

TAOPTaoping Inc

TLSATiziana Life Sciences Ltd

Spero Therapeutics, Inc. (NASDAQ:SPRO) rose 105.6% to $1.69 in pre-market trading. GSK and Spero Therapeutics announced exclusive license agreement for late-stage antibiotic asset, Tebipenem HBr.
HeartBeam, Inc. (NASDAQ:BEAT) shares rose 27.8% to $2.02 in pre-market trading after dropping 16% on Wednesday. Heartbeam recently announced its patent for a 12-lead electrocardiogram patch monitor intended for detection of acute coronary syndrome and cardiac arrhythmia was issued by the USPTO.
American Virtual Cloud Technologies, Inc. (NASDAQ:AVCT) rose 20.1% to $0.2590 in pre-market trading.
Taoping Inc. (NASDAQ:TAOP) rose 19.7% to $0.73 in pre-market trading. Taoping recently posted 1H revenue of $10.5 million.
Acorda Therapeutics, Inc. (NASDAQ:ACOR) rose 18.4% to $0.3672 in pre-market trading after declining around 7% on Wednesday.
Lytus Technologies Holdings PTV. Ltd. (NASDAQ:LYT) rose 15.8% to $1.90 in pre-market trading after dropping over 5% on Wednesday.
Organovo Holdings, Inc. (NASDAQ:ONVO) rose 15.3% to $2.45 in pre-market trading.
Ensysce Biosciences, Inc. (NASDAQ:ENSC) rose 12% to $0.2660 in pre-market trading after declining 5% on Wednesday.
Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA) rose 11.2% to $1.98 in pre-market trading after declining over 4% on Wednesday.
Timber Pharmaceuticals, Inc. (NYSE:TMBR) rose 10.3% to $0.1138 in pre-market trading. Timber Pharmaceuticals recently received positive opinion on Orphan Designation from European Medicines Agency For TMB-001.
SmartRent, Inc. (NYSE:SMRT) rose 8.1% to $2.93 in pre-market trading after gaining around 7% on Wednesday.
Deutsche Bank Aktiengesellschaft (NYSE:DB) rose 6.3% to $9.14 in pre-market trading. Deutsche Bank said its New York Branch, Deutsche Bank New York, and its affiliate Deutsche Bank Trust Company Americas have raised their prime lending from 5.50% to 6.25%.

Soluna Holdings, Inc. (NASDAQ:SLNH) fell 11.9% to $1.48 in pre-market trading after gaining around 6% on Wednesday.
Tiziana Life Sciences Ltd (NASDAQ:TLSA) shares fell 11.6% to $0.6899 in pre-market trading after jumping 10% on Wednesday. Tiziana Life Sciences announced purchase of 20,145 common shares by Executive Chairman.
ECMOHO Limited (NASDAQ:MOHO) fell 9.4% to $0.1580 in pre-market trading after jumping over 50% on Wednesday.
China Pharma Holdings, Inc. (NYSE:CPHI) shares fell 8.6% to $0.1411 in pre-market trading.
Evaxion Biotech A/S (NASDAQ:EVAX) fell 8.5% to $2.13 in pre-market trading. Evaxion Biotech shares gained 14% on Wednesday after the company announced it reached an important milestone announcing today that it had enrolled its first patient in the global phase 2b clinical trial of EVX-01.
Brenmiller Energy Ltd (NASDAQ:BNRG) fell 7.7% to $3.56 in pre-market trading.
FOXO Technologies Inc. (NYSE:FOXO) fell 7.1% to $2.08 in pre-market trading after gaining over 6% on Wednesday.
Novavax, Inc. (NASDAQ:NVAX) fell 5.3% to $24.50 in pre-market trading. JP Morgan downgraded Novavax from Neutral to Underweight and lowered the price target from $132 to $27.
Ocular Therapeutix, Inc. (NASDAQ:OCUL) shares fell 4.3% to $5.56 in pre-market trading after declining 5% on Wednesday.

BEATHeartBeam Inc

BNRGBrenmiller Energy Ltd

CMRAComera Life Sciences Holdings Inc

$0.00010-100.0%

CPHIChina Pharma Holding Inc

DBDeutsche Bank AG

ENSCEnsysce Biosciences Inc

FOXOFOXO Technologies Inc

NVAXNovavax Inc

OCULOcular Therapeutix Inc

SLNHSoluna Holdings Inc

SMRTSmartRent Inc

SPROSpero Therapeutics Inc

TAOPTaoping Inc

TLSATiziana Life Sciences Ltd

Comments

Loading...